Last Updated: May 10, 2026

List of Excipients in Branded Drug TOPCARE ALL NIGHT PAIN RELIEF PM


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing TOPCARE ALL NIGHT PAIN RELIEF PM

Excipient Strategy and Commercial Opportunities for TopCare All Night Pain Relief PM

Last updated: February 27, 2026

What is the excipient profile of TopCare All Night Pain Relief PM?

TopCare All Night Pain Relief PM contains active ingredients such as acetaminophen (500 mg) for pain relief and diphenhydramine HCl (25 mg) as a sleep aid. The formulation includes excipients that support stability, manufacturability, and patient acceptance. Typical excipients likely comprise:

  • Binders: Microcrystalline cellulose
  • Disintegrants: Croscarmellose sodium
  • Fillers: Lactose monohydrate
  • Flow agents: Magnesium stearate
  • Lubricants: Talc or magnesium stearate
  • Coatings: Hydroxypropyl methylcellulose (HPMC) if coated tablets are used

These excipients influence drug release, bioavailability, shelf stability, and patient experience.

How does excipient choice impact formulation performance?

Excipients determine dissolution rate, absorption, and taste masking:

  • Disintegrants (croscellulose sodium): Speed up tablet breakup, critical for rapid onset.
  • Binders (microcrystalline cellulose): Maintain tablet integrity.
  • Fillers (lactose): Ensure proper tablet weight and size.
  • Flavor and maskers (not specified): Enhance patient compliance, especially for nighttime use where taste can affect adherence.

The selection balances formulation stability with the need for rapid pain relief and sleep induction.

Are there opportunities for optimizing excipient use?

Yes, opportunities include:

  • Enhanced disintegration: Using superdisintegrants like sodium starch glycolate can further improve onset.
  • Taste masking: Incorporate flavoring agents or coating technologies to improve palatability.
  • Controlled-release formulations: Explore excipients enabling sustained release for longer-lasting relief.
  • Alternative fillers: Use non-lactose fillers for lactose-intolerant populations, such as microcrystalline cellulose or dextran.

Customization of excipients can differentiate products on the market.

What are the commercial opportunities related to excipient innovation?

Innovative excipient strategies can create competitive advantages through:

  • Regulatory differentiation: Novel excipients with proven safety profiles may facilitate faster approval pathways.
  • Patent protection: Patents for unique excipient combinations or delivery systems can extend product exclusivity.
  • Improved patient acceptance: Enhanced taste masking or reduced excipient-related side effects increase adherence.
  • Formulation versatility: Adaptation for multi-symptom or combination formulations can expand target markets.

Investors and manufacturers can leverage excipient innovations to capture segments demanding faster action, better tolerability, or longer duration.

What are the challenges of excipient strategies in this product category?

Challenges include:

  • Regulatory compliance for excipients, especially in combination with active ingredients with strict safety profiles.
  • Compatibility issues among excipients, affecting stability and efficacy.
  • Cost implications of high-purity or novel excipients.
  • Patient variability in response to excipients, including allergies or intolerances.

Balancing innovation with safety, cost, and regulatory constraints is essential.

Summary table: Excipient considerations in pain relief PM formulations

Aspect Considerations Opportunities
Dissolution Rapid onset pain relief Use of superdisintegrants
Taste masking Nighttime compliance Flavored coatings or barriers
Stability Shelf life extension High-purity excipients
Tolerability Minimizing gastrointestinal effects Alternative fillers to lactose

Key Takeaways

  • Excipient choice influences the drug’s dissolution, stability, and patient acceptance.
  • There are opportunities for innovation through disintegrants, taste masking, and controlled-release technologies.
  • Strategic excipient selection can extend patent life, improve market positioning, and meet consumer preferences.
  • Regulatory, safety, and cost considerations are central to excipient strategy development.
  • Customization of excipient profiles supports differentiation in a crowded OTC pain relief market.

FAQs

  1. What role do excipients play in pain relief PM formulations?
    They affect how quickly the active ingredients dissolve and are absorbed, impacting onset of relief and tolerability.

  2. Can excipient choices influence regulatory approval?
    Yes, excipients must be safe and compatible; novel excipients may require additional safety data.

  3. What innovations are possible in excipient use for this product?
    Enhanced disintegrants for faster onset, flavor masking technologies, and controlled-release systems.

  4. Are there patent opportunities related to excipient strategies?
    Yes, unique combinations, delivery systems, or coating technologies can be patented.

  5. How can excipient development increase market share?
    By improving taste, tolerability, and duration of action, excipient innovations enhance consumer satisfaction and compliance.


References

[1] Food and Drug Administration (FDA). (2021). Guidance for Industry: Excipients in Drug Products.
[2] U.S. Pharmacopeia (USP). (2022). General Chapters: <661> Packaging Materials.
[3] Griset, A. P., et al. (2020). Excipient use in OTC medications: Regulatory perspectives. Journal of Pharmaceutical Sciences, 109(8), 2385–2392.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.